Synergen MedTech

Blog

Practical thoughts on MedTech growth, markets and funding.

Insights from 30 Years in MedTech

Practical lessons on entrepreneurship, medical technology innovation, international business and leadership.

  • What’s new this week in MedTech, 7 to 13 November 2026

    What’s new this week in MedTech, 7 to 13 November 2026

    7 to 13 November 2026 A week shaped by the heart and by the money behind new therapies. Abbott won approval on both sides of the Atlantic for a new defibrillation lead, Johnson & Johnson backed a prostate cancer ablation company, Oura moved from measuring health into delivering care, and AHA 2026 gave us a…

  • What’s new this week in US MedTech, 5 to 12 November 2026

    What’s new this week in US MedTech, 5 to 12 November 2026

    5 to 12 November 2026 This is the first of a new Thursday series on US MedTech. It was a week in which the FDA both opened doors and closed one: two De Novo authorizations and a carotid PMA, a 510(k) in wound care, a CMS reversal that will pay for a new breast imaging…

  • What’s new this week in European MedTech, 4 to 11 November 2026

    What’s new this week in European MedTech, 4 to 11 November 2026

    4 to 11 November 2026 This is the first of a new Wednesday series on European MedTech. It was a week of steady, practical news rather than mega rounds: home dialysis and home stroke rehabilitation raised fresh money, sepsis and urology companies funded their next push across Europe, two European groups bought their way into…

  • How to Select the Right International Market for Your Medical Device

    How to Select the Right International Market for Your Medical Device

    When founders show me their international plans, there is often a map with a lot of flags on it. I understand the instinct, because the need for good medical technology is everywhere and every country looks like an opportunity from a distance. But international market entry for a medical device is expensive in time, money…

  • What’s new this week in MedTech funding and deals, 3 to 10 November 2026

    What’s new this week in MedTech funding and deals, 3 to 10 November 2026

    3 to 10 November 2026 This is the first of a new Tuesday series on MedTech funding and deals. It was a heavy week for capital: Boston Scientific and Blackstone agreed a large co-funding package for a heart pump, GE HealthCare led a major Series B for AI robotic imaging in the cath lab, Chinese…

  • What’s new this week in Asian MedTech, 2 to 8 November 2026

    What’s new this week in Asian MedTech, 2 to 8 November 2026

    2 to 8 November 2026 Another busy Asian week, led again by Chinese capital. Nanochap and Active Technology raised large rounds for implantable brain computer interfaces, Shanghai Yingjiexin closed a Series B for injection pens, and Rhino Health raised a B+ round to commercialise China’s first homegrown phaco vitrectomy system. Taiwan’s Ever Fortune.AI won a…

  • What’s new this week in Indian MedTech, 2 to 8 November 2026

    What’s new this week in Indian MedTech, 2 to 8 November 2026

    2 to 8 November 2026 A busy Indian week across funding, local manufacturing, critical care launches, import logistics, industry-academia ties and device safety: Clinics On Cloud raised Rs 120 crore in its first institutional round for CDSCO licensed Health ATMs, Omron Healthcare began full-scale production of blood pressure monitors at its first India factory near…

  • What’s new this week in Israeli MedTech, 31 October to 6 November 2026

    What’s new this week in Israeli MedTech, 31 October to 6 November 2026

    What’s new this week in Israeli MedTech 31 October to 6 November 2026 A strong Israeli week across funding, exits, hospital AI and clearances abroad: StimCardio raised a large Series A for a wearable AF therapy, TailorMed took a reported quarter billion dollar majority deal, ZOLL Itamar and MeMed both advanced US clearances, Ichilov partnered…

  • They Saw the Future. They Waited.

    They Saw the Future. They Waited.

    Kodak helped invent the digital camera. Blockbuster was offered a partnership with Netflix. Nokia held almost 40% of the world’s phone market. All three saw the future coming, and all three chose to protect what was already working. That one mistake cost them everything. I see the same pattern in MedTech all the time. A…